United Therapeutics Corp banner

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 477.645 USD -1.53% Market Closed
Market Cap: $20.6B

Balance Sheet

Balance Sheet Decomposition
United Therapeutics Corp

Balance Sheet
United Therapeutics Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
123
68
83
69
91
139
130
100
252
163
154
284
398
832
1 023
705
669
738
739
895
961
1 208
1 697
1 557
Cash Equivalents
123
68
83
69
91
139
130
100
252
163
154
284
398
832
1 023
705
669
738
739
895
961
1 208
1 697
1 557
Short-Term Investments
0
0
0
56
137
151
107
129
375
241
325
410
298
122
28
222
747
748
1 096
1 036
1 878
1 786
1 570
1 363
Total Receivables
10
11
16
19
26
30
31
53
74
89
117
126
162
193
215
297
176
151
157
199
220
279
279
350
Accounts Receivables
10
10
14
14
23
26
28
51
74
89
117
126
162
193
215
297
176
151
157
199
220
279
279
350
Other Receivables
0
1
2
5
3
4
2
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
7
8
8
11
12
13
14
26
36
46
37
48
67
81
100
108
101
93
87
94
102
112
158
183
Other Current Assets
2
2
4
11
12
20
16
15
28
24
35
46
49
47
60
116
75
134
88
100
219
166
170
249
Total Current Assets
142
90
111
167
277
353
297
325
765
563
669
914
974
1 275
1 425
1 448
1 768
1 865
2 167
2 324
3 380
3 551
3 874
3 703
PP&E Net
9
15
18
22
35
69
223
304
306
366
454
465
478
496
489
546
700
743
732
781
862
1 045
1 222
1 730
PP&E Gross
9
15
18
22
35
69
223
304
306
366
454
465
478
496
489
546
700
743
732
781
862
1 045
1 222
1 730
Accumulated Depreciation
3
4
6
8
9
10
14
23
38
53
78
106
135
155
175
203
235
269
309
342
383
428
491
568
Intangible Assets
7
6
6
6
3
1
0
10
7
14
6
3
19
18
24
32
139
130
130
17
17
81
80
84
Goodwill
8
8
8
8
8
8
8
9
3
8
11
11
10
10
10
14
32
28
28
28
28
34
32
32
Note Receivable
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
17
56
54
53
41
10
100
149
133
344
306
448
123
38
2
503
443
768
1 150
1 650
1 316
1 938
1 534
1 831
Other Long-Term Assets
2
3
11
37
113
147
246
256
218
224
182
246
280
347
375
338
320
380
409
370
442
518
622
501
Other Assets
8
8
8
8
8
8
8
9
3
8
11
11
10
10
10
14
32
28
28
28
28
34
32
32
Total Assets
185
N/A
180
-3%
207
+15%
291
+41%
477
+64%
587
+23%
875
+49%
1 052
+20%
1 432
+36%
1 518
+6%
1 627
+7%
2 088
+28%
1 884
-10%
2 184
+16%
2 326
+6%
2 879
+24%
3 401
+18%
3 913
+15%
4 615
+18%
5 169
+12%
6 045
+17%
7 167
+19%
7 364
+3%
7 880
+7%
Liabilities
Accounts Payable
5
4
6
4
3
2
20
19
16
47
10
7
7
8
8
8
23
10
4
4
4
6
6
7
Accrued Liabilities
5
6
8
10
15
18
21
30
50
57
68
80
71
88
96
163
143
140
183
171
226
292
339
481
Short-Term Debt
0
0
0
0
0
0
0
220
236
0
1
283
127
5
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
0
0
0
250
0
0
0
0
0
0
0
0
0
0
0
250
0
0
0
400
300
0
Other Current Liabilities
0
0
0
0
1
3
17
61
126
108
97
319
300
340
228
274
111
63
136
131
113
106
94
73
Total Current Liabilities
9
11
14
15
19
273
58
330
429
213
177
688
504
441
333
445
277
463
323
305
343
804
738
561
Long-Term Debt
2
0
0
0
250
0
235
30
69
266
275
0
0
0
0
250
250
600
800
800
800
300
0
0
Other Liabilities
2
1
2
2
3
8
16
27
39
81
80
96
115
144
131
64
67
70
97
105
105
78
182
223
Total Liabilities
13
N/A
12
-9%
16
+32%
16
+5%
272
+1 571%
280
+3%
308
+10%
388
+26%
537
+38%
559
+4%
532
-5%
783
+47%
619
-21%
585
-5%
463
-21%
758
+64%
593
-22%
1 133
+91%
1 220
+8%
1 210
-1%
1 248
+3%
1 182
-5%
920
-22%
784
-15%
Equity
Common Stock
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Retained Earnings
186
196
180
115
41
22
94
75
31
249
554
728
1 068
1 720
2 434
2 846
3 435
3 325
3 839
4 315
5 042
6 027
7 222
8 557
Additional Paid In Capital
364
369
376
394
409
548
722
799
929
993
1 016
1 057
1 376
1 791
1 814
1 854
1 940
2 048
2 149
2 245
2 388
2 549
2 699
2 798
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
4
10
5
56
11
1
11
Treasury Stock
7
7
7
7
165
232
67
67
67
283
471
513
1 186
1 902
2 380
2 579
2 579
2 579
2 579
2 579
2 579
2 579
3 475
4 260
Other Equity
0
2
3
4
2
11
5
7
2
0
4
32
6
9
6
2
14
18
25
18
1
2
5
10
Total Equity
172
N/A
168
-2%
192
+14%
275
+44%
205
-26%
307
+50%
566
+85%
664
+17%
895
+35%
959
+7%
1 095
+14%
1 304
+19%
1 266
-3%
1 600
+26%
1 862
+16%
2 121
+14%
2 808
+32%
2 780
-1%
3 395
+22%
3 959
+17%
4 797
+21%
5 985
+25%
6 444
+8%
7 096
+10%
Total Liabilities & Equity
185
N/A
180
-3%
207
+15%
291
+41%
477
+64%
587
+23%
875
+49%
1 052
+20%
1 432
+36%
1 518
+6%
1 627
+7%
2 088
+28%
1 884
-10%
2 184
+16%
2 326
+6%
2 879
+24%
3 401
+18%
3 913
+15%
4 615
+18%
5 169
+12%
6 045
+17%
7 167
+19%
7 364
+3%
7 880
+7%
Shares Outstanding
Common Shares Outstanding
42
43
45
47
43
45
53
54
58
54
50
50
47
46
43
43
44
44
45
45
46
47
45
44
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett